The effect of pentoxifylline on ventricular arrhythmia
- Conditions
- Ventricular arrhythmia.Paroxysmal tachycardia
- Registration Number
- IRCT20220516054874N16
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 72
Age older than 18 years old
Heart failure diagnosis
ICD implantation > 6 months before eligibility test
Signed written informed consent to participate in the study
Using Pentoxifylline or other methyl Methylxanthines
New York Heart Association Class IV heart failure
Renal dysfunction with eGFR < 30
Hepatic dysfunction
Body mass index < 18.5 kg/m2
Pregnant or suspected pregnancy
Patients with the following events within 3months before the eligibility test: alteration of antiarrhythmic drug, catheter ablation for ventricular arrhythmia, coronary revascularization, open-heart surgery, development of coronary artery disease, stroke or transient ischemic stroke, seizure, infection requiring hospitalization, heart failure requiring hospitalization
Other comorbidities including various infections, major surgery, type 1 diabetes, pituitary or adrenal insufficiency, cancer
ICDs unable to record cardiac arrhythmias
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method